KALA
Kala Pharmaceuticals Inc
Halal Rating :
Last Price
$7.23
Last updated:
Market Cap
-
7D Change
10.38%
1 Year Change
1.69%
Company Overview
Industries
Exchange
Next Earnings Date
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for rare diseases of the eye. The company's lead product candidate is KPI-012, which is being developed for the treatment of persistent corneal epithelial defects (PCED), a rare disease of the eye.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Kala Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.